TY  - RPRT
TI  - CV2CoV, an enhanced mRNA-based SARS-CoV-2 vaccine candidate, supports higher protein expression and improved immunogenicity in rats
AU  - Roth, N.
AU  - Schoen, J.
AU  - Hoffmann, D.
AU  - Thran, M.
AU  - Thess, A.
AU  - Mueller, S. O.
AU  - Petsch, B.
AU  - Rauch, S.
PY  - 2021
DO  - 10.1101/2021.05.13.443734
UR  - https://www.biorxiv.org/content/10.1101/2021.05.13.443734v1
ID  - 10.1101/2021.05.13.443734
ER  -